Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.730
-0.070 (-3.89%)
Feb 21, 2025, 4:00 PM EST - Market closed

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $9.87 million. The enterprise value is $10.54 million.

Market Cap 9.87M
Enterprise Value 10.54M

Important Dates

The next estimated earnings date is Monday, March 31, 2025, before market open.

Earnings Date Mar 31, 2025
Ex-Dividend Date n/a

Share Statistics

BCLI has 5.70 million shares outstanding. The number of shares has increased by 69.79% in one year.

Current Share Class 5.70M
Shares Outstanding 5.70M
Shares Change (YoY) +69.79%
Shares Change (QoQ) +11.84%
Owned by Insiders (%) 14.72%
Owned by Institutions (%) 7.24%
Float 4.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio -1.63
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio 0.05
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -35.02

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -215.84%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 263.16%
Revenue Per Employee n/a
Profits Per Employee -$490,621
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.96% in the last 52 weeks. The beta is 0.25, so BCLI's price volatility has been lower than the market average.

Beta (5Y) 0.25
52-Week Price Change -67.96%
50-Day Moving Average 1.97
200-Day Moving Average 3.75
Relative Strength Index (RSI) 40.60
Average Volume (20 Days) 41,068

Short Selling Information

The latest short interest is 91,385, so 1.60% of the outstanding shares have been sold short.

Short Interest 91,385
Short Previous Month 172,989
Short % of Shares Out 1.60%
Short % of Float 2.06%
Short Ratio (days to cover) 1.50

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -13.31M
Pretax Income -15.53M
Net Income -14.23M
EBITDA -13.06M
EBIT -13.31M
Earnings Per Share (EPS) -$3.20
Full Income Statement

Balance Sheet

The company has $168,000 in cash and $841,000 in debt, giving a net cash position of -$673,000 or -$0.12 per share.

Cash & Cash Equivalents 168,000
Total Debt 841,000
Net Cash -673,000
Net Cash Per Share -$0.12
Equity (Book Value) -6.06M
Book Value Per Share -1.14
Working Capital -6.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.33 million and capital expenditures -$18,000, giving a free cash flow of -$11.35 million.

Operating Cash Flow -11.33M
Capital Expenditures -18,000
Free Cash Flow -11.35M
FCF Per Share -$1.99
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -69.79%
Shareholder Yield -69.79%
Earnings Yield -144.20%
FCF Yield -115.01%

Analyst Forecast

The average price target for BCLI is $30.00, which is 1,634.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target $30.00
Price Target Difference 1,634.10%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Oct 1, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1